- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01576991
Telomeres and Reproduction in Women
August 9, 2013 updated by: University of South Florida
The purpose of the study is to describe the relationship between leukocyte, granulose cell and polar body telomere length, telomere injury foci (TIFs), polarized light microscopy of oocyte spindles and their frequency in the eggs from older women and associations with aneuploidy.
Study Overview
Status
Completed
Conditions
Detailed Description
The chances of conception decrease and miscarriage increase with a women's age, and the locus of reproductive aging is the egg (1).
Egg dysfunction affects most women beginning by their late '30's and for many women age related egg dysfunction represents a major cause of infertility.
The cause of age related egg dysfunction is poorly understood, but telomere dysfunction may play an important role.
Our group has demonstrated that genetic or pharmacologic shortening of telomeres in the eggs of mice, which normally do not exhibit age related egg dysfunction, mimics reproductive aging in women, with cell cycle arrest, apoptosis, spindle dysmorphologies and chromosomal abnormalities (1,2).
Moreover, a pilot study the investigators conducted five years ago suggested that telomere length of spare human eggs may predict the outcome of womens' InVitro Fertilization (IVF) cycles (3).
Subsequently, other investigators have demonstrated that telomere length of circulating leukocytes predicts miscarriages (4).
Study Type
Observational
Enrollment (Actual)
145
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
InVItro Fertilization patients undergoing therapy
Description
Inclusion Criteria:
- Ages 18 to 48
- Undergoing InVitro Fertilization
- Willing to donate spare eggs, granulosa cells and blood
- Willing to give written informed consent
Exclusion Criteria:
- Not undergoing InVitro Fertilization
- Not willing to donate spare eggs, granulosa cells or blood
- Not willing to give written informed consent
- Previously donated spare eggs, granulosa cells or blood for this research project
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Oocyte collection
This is an observational study; there are no cohorts or groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Telomere length
Time Frame: 1 year
|
Describe the relationship between leukocyte, granulose cell and polar body telomere length, telomere injury foci (TIFs), polarized light microscopy of oocyte spindles
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of telomeres
Time Frame: 1 year
|
The Primary outcome frequencies in the eggs from older women and associations with aneuploidy.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Celso Silva, MD, University of South Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
April 10, 2012
First Submitted That Met QC Criteria
April 11, 2012
First Posted (Estimate)
April 13, 2012
Study Record Updates
Last Update Posted (Estimate)
August 13, 2013
Last Update Submitted That Met QC Criteria
August 9, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 108093
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on InVitro Fertilization
-
Cairo UniversityCompleted
-
Cairo UniversityUnknown
-
Cairo UniversityCompleted
-
Centrum Clinic IVF CenterRecruitingInVitro Fertilization | GonadotropinsTurkey (Türkiye)
-
Cairo UniversityCompleted
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
Cairo UniversityUnknownInvitro FertilizationEgypt